The average clinical trial waits 56 days for the first enrolled patient. With Hekma AI-powered patient identification, that number drops to under 3 weeks.
Only 6% of US cancer patients participate in clinical trials β not because they do not want to, but because they never find out they qualify. McKinsey, 2024
Pre-screened pool: 847 likely-eligible patients
Screen failure rate: 60% β under 20%
5 Sourcing Channels Running Simultaneously
A tiered patient pool with documented eligibility scores (100% / 80% / 50% confidence) delivered to your site coordinators β with pre-screening summaries so the first call is a qualification conversation, not a cold introduction.
FHIR API connection to hospital EHRs. Passively screens patient records against your I/E criteria without physician involvement.
Proprietary patient database from the Human 360 app. Verified records, active interest, documented eligibility. Highest-quality leads.
50+ patient advocacy groups across cardiology, oncology, CNS, and rare disease. PAG referrals convert 3Γ higher than cold social.
IRB-approved campaigns across Facebook, Instagram, Google, and condition-specific platforms. Built for your indication, geography, and demographics.
Direct outreach through hospital network to identify eligible patients via care teams. For complex rare disease and oncology trials.
Key Stat
60% β 20%
Screen failure rate with pre-screened, eligibility-scored patients.
Tufts CSDD, 2024
Integrations
Using EHR network matching against 23,000 hospital records, pre-screened candidates delivered to 4 sites in 11 days.
Read more βTraditional site outreach had returned zero candidates after 8 weeks. Hekma identified 12 eligible patients within 21 days.
Read more βCompliance & Standards
Give us one trial protocol. We activate all 5 sourcing channels and deliver pre-screened candidates to your sites.